Christopher Powala is a serial entrepreneur with over 34 years of experience in the pharmaceutical/biotech industry. Mr. Powala joined NFlection Therapeutics as President & CEO in June 2019. Mr. Powala co-founded and served as Chief Development Officer of Aclaris Therapeutics until his retirement in June 2019. He also served as the Co-Founder & Chief Operating Officer of Vicept Therapeutics, Inc. from 2009 until its acquisition by Allergan, Inc. in July 2011. Prior to joining Vicept Therapeutics, Inc., from 2008 to 2009, he served as Vice President, Clinical Operations & Global Regulatory Affairs for Vital Therapies, Inc., a biotechnology company. From 1993 to 2008, Mr. Powala was with CollaGenex Pharmaceuticals, Inc, a dermatology-focused specialty pharmaceutical company, where he served as Vice President, Drug Development and Regulatory Affairs. Previously, Mr. Powala held various positions in product development and regulatory affairs at Wyeth Laboratories, Inc. Mr. Powala received his Post-Baccalaureate Certificate in General Management from the Wharton School, University of Pennsylvania, and his bachelor’s degree in Biology from State University of New York-Regents College.